It appears that the elevated levels of TGF-β and IL-1β observed in the subset of neutrophilic asthma patients [comprising 20%-30% of asthmatic patients (77)] may be responsible for the differences in the association of asthma and AR with metabolic dysregulations. The gene discussed is IL1B; the disease is asthma.